Hunan Huiyisen Cell Gene Engineering

Hunan Huiyisen Cell Gene Engineering is a biotechnology company headquartered in Changsha, China, dedicated to advancing regenerative medicine through cell and gene engineering. The company primarily focuses on the development and characterization of human umbilical cord mesenchymal stem cells (HUCMSCs), with a specific emphasis on their role in osteogenesis and the treatment of bone-related conditions. In addition to its therapeutic research, Huiyisen manufactures specialized laboratory equipment designed to improve the efficiency of cell processing, including automated batch cell resuscitation systems and micro-tissue fragmentation devices. The company's research initiatives, often conducted in collaboration with leading academic institutions such as the Chinese Academy of Sciences, investigate the regulatory effects of vitamin D3 on stem cell differentiation. By combining therapeutic development with innovative hardware solutions, Huiyisen aims to streamline the clinical translation of cell-based therapies.